Condition

SGLT2 Inhibitors clinical trials and research

As of November 12, 2026, Find a Trial lists 3 SGLT2 Inhibitors clinical trials that are recruiting, at sites in 3 countries (most in China (1), Hong Kong (1), Romania (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest SGLT2 Inhibitors clinical trials

StudyPhaseWhereStatusRegistered
Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS Phase 4 Shenyang, Liaoning Recruiting Jan 20, 2026
Cardio-renal outcomes with SGLT2 inhibitors in CKD patients with HFpEF — Iași Recruiting Nov 19, 2025
Testing SGLT2 inhibitors for treating sepsis in adults — Hong Kong, Hong Kong and 2 other locations Recruiting Jun 25, 2024

All recruiting trials (3)

Related topics

ACS (Acute Coronary Syndrome)CKD - Chronic Kidney DiseaseCritically IllDiabetes (DM)Heart Failure Preserved Ejection FractionSepsis

Quick answers

How many SGLT2 Inhibitors clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), Hong Kong (1 trial), Romania (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.